Treatment options for gynecological cancers have become more effective and diverse in the last few decades. In this video, Marcia Hall, MBBS, PhD, FRCP, of the East and North Hertfordshire NHS Trust, Hertfordshire, UK, gives an overview of these developments, as well as her perspective on the current state and future of gynecological cancer care, at the UK Oncology Forum (OF) 2018, held in Liverpool, UK. She dsicusses how increased understanding of disease complexity and pathology, in combination with the development of new pharmaceutical and targeted therapies, has transformed gyneocological cancer prognoses, meaning an increasing number of patients can either be cured, or live with their cancer much like a chronic illness. Finally, Dr Hall discusses the prospect of immunotherapy in gynecological cancers, and while she does not predict great success with such treatments, she suggests that screening and targeting certain patient populations with greater mutational burdens might be effective.
Gynecological cancer treatments: past, present, and future
